Effects of fluvastatin on serum sICAM-1 and sVCAM-1 in patients with congestive heart failure
Zheng Xiaoming
Abstract
Zheng Xiaoming
Abstract
AIM:To observe the effects of short-term treatment of fluvastatin on serum soluble intercellular adhesion molecule-1(sICAM-1),soluble vascular cell adhesion molecule-1(sVCAM-1) and tumor necrosis factor-α(TNF-α) in patients with congestive heart failure(CHF).METHODS:Ninety seven patients with CHF were randomly divided into control group(conventional treatment group) and test drug group(fluvastatin group).Levels of serum sICAM-1,sVCAM-1 and TNF-α were measured using enzyme-linked immunosorbent assay(ELISA) before treatment and after 2 weeks of treatment.RESULTS:Both methods can significantly reduce serum sICAM-1,sVCAM-1 and TNF-α level(P0.05).TNF-α levels of test drug groups reduced more significantly(P0.05),whereas decreased levels of serum sICAM-1 and sVCAM-1 had no significant difference compared with control group.CONCLUSION:On the basis of conventional treatment together with short-term fluvastatin treatment,no further reduction of the levels of sICAM-1 and sVCAM-1 were demonstrated.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM:To observe the effects of short-term treatment of fluvastatin on serum soluble intercellular adhesion molecule-1(sICAM-1),soluble vascular cell adhesion molecule-1(sVCAM-1) and tumor necrosis factor-α(TNF-α) in patients with congestive heart failure(CHF).METHODS:Ninety seven patients with CHF were randomly divided into control group(conventional treatment group) and test drug group(fluvastatin group).Levels of serum sICAM-1,sVCAM-1 and TNF-α were measured using enzyme-linked immunosorbent assay(ELISA) before treatment and after 2 weeks of treatment.RESULTS:Both methods can significantly reduce serum sICAM-1,sVCAM-1 and TNF-α level(P0.05).TNF-α levels of test drug groups reduced more significantly(P0.05),whereas decreased levels of serum sICAM-1 and sVCAM-1 had no significant difference compared with control group.CONCLUSION:On the basis of conventional treatment together with short-term fluvastatin treatment,no further reduction of the levels of sICAM-1 and sVCAM-1 were demonstrated.
Key concepts: Fluvastatin, Medicine, Heart failure, Tumor necrosis factor alpha, Internal medicine, Intercellular Adhesion Molecule-1, Tumor necrosis factor α, Pharmacology